asenapine 2.5 mg

DRUG2 trials

Sponsors

Organon and Co

Conditions

Bipolar I DisorderSchizophreniaSchizophrenia, DisorganizedSchizophrenia, ParanoidSchizophrenia, Undifferentiated

Phase 1

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Sublingual Asenapine in a Pediatric Population With Schizophrenia or Bipolar I Disorder (P06522 AM1)

CompletedNCT01206517

Organon and CoBipolar I Disorder, Schizophrenia

Start: 2010-07-18End: 2011-08-04Updated: 2024-05-23

Phase 3

Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)

CompletedNCT01190254

Organon and CoSchizophrenia, Disorganized, Schizophrenia, Paranoid, Schizophrenia, Undifferentiated

Start: 2010-09-28End: 2013-04-01Updated: 2024-05-21

Related Papers

Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with Schizophrenia

Journal of Child and Adolescent Psychopharmacology2015-06-0146 citations